Smart insulin pump could ease diabetes management for kidney patients on dialysis
NCT ID NCT07422532
First seen Feb 21, 2026 · Last updated Jun 23, 2026 · Updated 20 times
Summary
This study tests whether an automated insulin delivery system (the Omnipod 5) can help people with type 2 diabetes who are on dialysis achieve better blood sugar control. Half of the 84 participants will use the automated system, while the other half will continue their usual insulin injections. The goal is to see if the device improves glucose levels and quality of life over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guys and St Thomas' Hospitals
London, United Kingdom
Contact Email: •••••@•••••
Contact
-
Hammersmith Hospital
London, United Kingdom
Contact Email: •••••@•••••
-
Manchester Royal Infirmary
Manchester, United Kingdom
Contact Email: •••••@•••••
-
Royal Derby Hospital
Derby, United Kingdom
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Omnipod 5 automated insulin delivery system
What this could lead to
If it works, this could offer a safer, easier way for people with type 2 diabetes on dialysis to manage their blood sugar without constant finger-prick tests.
What could go wrong
This is a small, early-stage trial with only 84 participants. The device is not yet proven for this specific group, and results may not apply to everyone. There is also a risk of device malfunction or low blood sugar.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.